|
|
 |
|
Viewing report
|
|
|
|
Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
GBI Research, Sep 2010, Pages: 156
“Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies” provides the key data and analyzes the major challenges and drivers for the biomanufacturing industry. The report also analyzes the strengths, weaknesses of and opportunities for the stakeholders in the manufacturing of biologics. The report also discusses the key market drivers and barriers for the growth of biomanufacturing in the pharmaceutical and biotech industry.
The report is based on proprietary databases, primary and secondary research and in-house analysis by a team of industry experts to provide a comprehensive view of the manufacturing of biologics.
Scope
The scope of this report includes:
- Opportunities and challenges for manufacturers of biologics in the pharmaceuticals industry
- Market revenues and forecasts for biologics manufacturing in the global pharmaceutical industry from 2009 to 2016.
- The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China.
- Processes involving the manufacturing of biologics including upstream and downstream bioprocessing.
- Technology trends in upstream and downstream bioprocessing that shape the biomanufacturing industry and regulatory trends in the key markets.
- Production capacities for the mammalian and microbial manufacturing facilities in the key regions.
- Qualitative analysis of the market drivers, barriers, future outlook and challenges for the manufacturing of biologics in the pharmaceutical industry
- Analysis of competitive landscape and the leading market players.
Reasons to buy
The report will enhance your decision making capability. It will allow you to:
- Formulate strategies to increase your company’s growth by understanding the new growth opportunities in the market for manufacturing of biologics
- Work around the regulatory and technology hurdles by identifying the key trends shaping and driving the market for biomanufacturing.
- Differentiate yourself from competitors and develop new solutions for the biomanufacturing industry by understanding the current competitive landscape and how it is evolving to meet the increasing demands
- Draft efficient strategies by understanding best practices, identifying key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Make more informed business decisions from the insightful and in-depth analysis of the market for biomanufacturing by analyzing the key technology trends that shape the growth of this market
Customers who bought this item also bought
Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost - Effective Purification Technologies
Biomanufacturing Strategies: Market Drivers, Build-vs-Buy Decisions and Opportunities in Contract Relationship Management
The CMO Market Outlook: Emerging Markets, Key Players and Future Trends
The Future of Contract Manufacturing - Market Forecasts to 2015 and Key Trends
Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
Manufacturing of Solid Dosage Forms - 2011
Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013
The Top 10 CMOs in India: Market Dynamics, Competitive Positioning and Trends
The New Trend of API Sourcing and Contract Manufacturing in China
|
|
|
|
